Showing results (31-40 of 46) with videos related to

Sort By:
Pageof 5
The Prostate|November 1, 2006
Sulfasalazine-induced cystine starvation: potential use for prostate cancer therapyDaniel W Doxsee, Peter W Gout, Takeshi Kurita, et al.
Antioxidants & Redox Signaling|June 7, 2012
The cystine/glutamate antiporter system x(c)(-) in health and disease: from molecular mechanisms to novel therapeutic opportunitiesJan Lewerenz, Sandra J Hewett, Ying Huang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 5, 2006
Establishment in severe combined immunodeficiency mice of subrenal capsule xenografts and transplantable tumor lines from a variety of primary human lung cancers: potential models for studying tumor progression-related changesJean-Claude Cutz, Jun Guan, Jane Bayani, et al.
Cancer Research|June 4, 2008
ASAP1, a gene at 8q24, is associated with prostate cancer metastasisDong Lin, Akira Watahiki, Jane Bayani, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 25, 2016
BIRC6 Targeting as Potential Therapy for Advanced, Enzalutamide-Resistant Prostate CancerIris Sze Ue Luk, Raunak Shrestha, Hui Xue, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 25, 2010
Patient-derived first generation xenografts of non-small cell lung cancers: promising tools for predicting drug responses for personalized chemotherapyXin Dong, Jun Guan, John C English, et al.
Cancer Medicine|June 16, 2018
Targeting MCT4 to reduce lactic acid secretion and glycolysis for treatment of neuroendocrine prostate cancerStephen Yiu Chuen Choi, Susan L Ettinger, Dong Lin, et al.
Oncotarget|May 3, 2017
Metabolic heterogeneity signature of primary treatment-naïve prostate cancerDong Lin, Susan L Ettinger, Sifeng Qu, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology|September 13, 2005
An orthotopic metastatic prostate cancer model in SCID mice via grafting of a transplantable human prostate tumor lineYuwei Wang, Hui Xue, Jean-Claude Cutz, et al.
Oncotarget|December 30, 2014
Identification of DEK as a potential therapeutic target for neuroendocrine prostate cancerDong Lin, Xin Dong, Kendric Wang, et al.
Pageof 5